Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in England
- PMID: 31715210
- DOI: 10.1016/j.jinf.2019.11.001
Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in England
Abstract
Background: Invasive meningococcal disease (IMD) typically presents as meningitis, septicaemia or both. Atypical clinical presentations are rare but well-described. We aimed to assess the relationship between meningococcal capsular group, age, clinical presentation, diagnosis and outcome among IMD cases diagnosed in England during 2014.
Methods: Public Health England conducts enhanced national surveillance of IMD in England. Clinical data for laboratory-confirmed MenB, MenW and MenY cases in ≥5 year-olds were used to classify presenting symptoms, diagnosis and outcomes. Multivariable logistic regression was used to assess independent associations between meningococcal capsular group, clinical presentation, gender, age and death.
Results: In 2014, there were 340 laboratory-confirmed IMD cases caused by MenB (n = 179), MenW (n = 95) and MenY (n = 66). Clinical presentation with meningitis alone was more prevalent among MenB cases (28%) and among 15-24 year-olds (20%), whilst bacteraemic pneumonia was most prevalent among MenY cases (26%) and among ≥65 year-olds (24%). Gastrointestinal symptoms were recorded preceding or during presentation in 15% (40/269) cases with available information, including 5% (7/140) MenB, 17% (8/47) MenY and 30% (25/82) MenW cases. Upper respiratory tract symptoms were reported in 16% (22/141) MenB, 23% (11/47) MenY and 31% (26/84) MenW cases. Increasing age was also independently associated with bacteraemic meningococcal pneumonia, with no cases among 5-14 year-olds compared to 24% in ≥65 year-olds. Case fatality rates increased with age but no significant associations with death were identified.
Conclusions: Healthcare professionals should be aware of the atypical clinical presentations associated with the less prevalent meningococcal capsular groups in different age-groups.
Keywords: Atypical presentation; Gastrointestinal symptoms; Meningococcal disease; Meningococcal pneumonia; Outcome.
Copyright © 2019. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest HC, NA, SP, SR and MER have no personal competing interests. PHE National Infection Service, Immunisation and Countermeasures Division has provided vaccine manufactures with post-marketing surveillance reports which the Marketing Authorisation Holders are required to submit to the UK Licensing authority in compliance with their Risk Management Strategy. A cost recovery charge is made for these reports. SL performs contract work on behalf of St George’s university of London for GlaxoSmithKline, Pfizer, and Sanofi Pasteur. RB, JL and SJG perform contract research on behalf of Public Health England for GlaxoSmithKline, Pfizer, and Sanofi Pasteur. None of these authors receive personal remuneration.
Similar articles
-
Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales.Clin Infect Dis. 2015 Feb 15;60(4):578-85. doi: 10.1093/cid/ciu881. Epub 2014 Nov 10. Clin Infect Dis. 2015. PMID: 25389259
-
Clinical diagnoses and outcomes of 4619 hospitalised cases of laboratory-confirmed invasive meningococcal disease in England: Linkage analysis of multiple national databases.J Infect. 2016 Nov;73(5):427-436. doi: 10.1016/j.jinf.2016.07.016. Epub 2016 Jul 28. J Infect. 2016. PMID: 27475788
-
Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines.Vaccine. 2012 May 21;30(24):3710-6. doi: 10.1016/j.vaccine.2012.03.011. Epub 2012 Mar 17. Vaccine. 2012. PMID: 22429756
-
Epidemiology of invasive meningococcal disease in Greece, 2006-2016.Eur J Clin Microbiol Infect Dis. 2019 Dec;38(12):2197-2203. doi: 10.1007/s10096-019-03668-y. Epub 2019 Aug 15. Eur J Clin Microbiol Infect Dis. 2019. PMID: 31418100 Review.
-
Introduction of a second MenB vaccine into Europe - needs and opportunities for public health.Expert Rev Vaccines. 2019 Mar;18(3):225-239. doi: 10.1080/14760584.2019.1578217. Epub 2019 Mar 1. Expert Rev Vaccines. 2019. PMID: 30821535 Review.
Cited by
-
Invasive meningococcal disease in older adults: current perspectives and call for action.Eur Geriatr Med. 2024 Jun;15(3):729-741. doi: 10.1007/s41999-024-00969-0. Epub 2024 May 6. Eur Geriatr Med. 2024. PMID: 38709380 Free PMC article. Review.
-
Global epidemiology of serogroup Y invasive meningococcal disease: a literature review.Epidemiol Infect. 2024 Dec 5;152:e157. doi: 10.1017/S0950268824001535. Epidemiol Infect. 2024. PMID: 39635863 Free PMC article.
-
Geographical and temporal variations of serogroups and clonal types of Neisseria meningitidis involved in culture-confirmed invasive meningococcal disease in Canada, 2015-2023.J Med Microbiol. 2025 Mar;74(3):001979. doi: 10.1099/jmm.0.001979. J Med Microbiol. 2025. PMID: 40071600 Free PMC article.
-
Epidemiology of invasive meningococcal disease in Canada, 2012-2019.Can Commun Dis Rep. 2022 May 5;48(5):228-236. doi: 10.14745/ccdr.v48i05a06. eCollection 2022 May 5. Can Commun Dis Rep. 2022. PMID: 37325257 Free PMC article.
-
Immunogenicity of primary and booster MenACWY-TT vaccination in older adults and the importance of IgM.NPJ Vaccines. 2025 Jun 5;10(1):115. doi: 10.1038/s41541-025-01180-3. NPJ Vaccines. 2025. PMID: 40473635 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical